Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-001115

CHAIRMAN AND CEO gave up 10,467 shares (to pay taxes)

  • CHAIRMAN AND CEO acquired 35,599 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ward Robert · CHAIRMAN AND CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-09-26 Exercise or conversion : show line 1 in the form +35,599 181,420 D
2019-09-26 Shares withheld for taxes : show line 2 in the form −10,467 $4.37 $45,741 170,953 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-09-26 Exercise or conversion : show line 3 in the form Restricted Stock Units −35,599 320,393 D
Loading xslF345X03/form4-09272019_040902.xml…